Updated data from phase 2 study reveals survival benefit
News
Rishi Sunak joins Prostate Cancer Research as an ambassador
Former UK PM advocates for national screening programme
Dubai garden blooms with Boehringer Ingelheim’s lung disease campaign
Awareness of interstitial lung disease raised at Miracle Garden
ICR researchers develop blood test to uncover how childhood tumours adapt
It is hoped that the approach will lead to more targeted treatments for childhood cancers
FDA approves Deciphera’s Romvimza for rare tumour type
Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations
UK study highlights importance of GP data in understanding atrial fibrillation
The common heart condition affects approximately 1.5 million people in the UK
NHS England launches first-ever breast cancer screening campaign
New data has shown that around a third of women do not attend screenings after being invited
Cambridge scientists develop ‘super test’ for prostate cancer
New test aims to revolutionise prostate cancer screening
Bath researchers awarded Wellcome grant for psychotic disorder study
New funding to investigate cognitive decline and brain ageing
Andembry treatment approved across Europe
Significant progress for hereditary angioedema condition
Illuccix therapy gets approval in the UK
Imaging agent to improve prostate cancer detection
Amlenetug receives FDA Fast Track Designation
Potential treatment for multiple system atrophy shows promise
Bimekizumab shows long-term efficacy in hidradenitis suppurativa
UCB’s BIMZELX reveals promising two-year data at EHSF 2025
Libtayo available in Scotland for cervical cancer patients
New immunotherapy offers hope for recurrent cervical cancer
Lynparza approved in Scotland for BRCA-mutated breast cancer patients
Treatment expands options for HER2-negative metastatic breast cancer
